TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012
TCL Archive ASCO Annual Meeting: New Approaches For Treatment of Hematologic Malignancies June 30, 2006
TCL Archive Patient Harm—Including One Death—Cited As Faculty Challenges MD Anderson Leadership September 20, 2013